Pharma News First-in-class Factor D inhibitor danicopan successfully controls haemolysis in untreated pati... Read more
Pharma News Acalabrutinib for previously treated CLL: as effective but better tolerated than ibrutinib Read more
Pharma News Adding eltrombopag to immunosuppressive therapy improves response in severe aplastic anaemia Read more
Pharma News Significant complete haematological response with daratumumab in light-chain amyloidosis Read more
Pharma News FDA approves Rylaze for acute lymphoblastic leukaemia and lymphoblastic lymphoma Read more
Pharma News Salvage autologous transplant and lenalidomide maintenance versus lenalidomide/dexamethasone f... Read more
Pharma News Chemotherapy-free treatment option to be offered to Chronic lymphocytic leukaemia patients Read more
Top
